This is part of how it keeps you feeling full and reduces appetite, but it can also create an uncomfortable side effect
Its also worth noting that, while relatively common, diarrhea is not a persistent side effect of semaglutide
Replication and Clinical Status Both BPC-157 and TB-500 were removed from FDA 503A Category 2 (Do-Not-Compound) effective April 22, 2026, though removal does not confer Category 1 status or compoundability
16,17 Whether GLP-1 RAs protect against lithium-induced nephrotoxicity is unknown, but its not without interest that nephroprotective mechanisms implicated with GLP-1 RAs in the treatment of T2DM-related kidney disease and tacrolimus-induced nephrotoxicity overlap with pathoetiologic mechanisms implicated with lithium-induced nephrotoxicity
However, no Phase II or Phase III randomized controlled trials have been published as of 2026, meaning the full safety profile particularly long-term effects, drug interactions, and dose-dependent risks remains incompletely characterized